Valproate alters dopamine signaling in association with induction of Par-4 protein expression.
Chromatin remodeling through histone modifications has emerged as a key mechanism in the pathophysiology of psychiatric disorders. Valproate (VPA), a first-line medication for bipolar disorder, is known to have histone deacetylase (HDAC) inhibitor activity, but the relationship between its efficacy...
Main Authors: | Saebom Lee, Jaehoon Jeong, Young-Un Park, Yongdo Kwak, Seol Ae Lee, Haeryun Lee, Hyeon Son, Sang Ki Park |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3454414?pdf=render |
Similar Items
-
Correction: Valproate Alters Dopamine Signaling in Association with Induction of Par-4 Protein Expression
by: Saebom Lee, et al.
Published: (2014-01-01) -
Correction: Valproate Alters Dopamine Signaling in Association with Induction of Par-4 Protein Expression.
by: Saebom Lee, et al.
Published: (2014-01-01) -
Cdk5 phosphorylates dopamine D2 receptor and attenuates downstream signaling.
by: Jaehoon Jeong, et al.
Published: (2013-01-01) -
Depression research: where are we now?
by: Lee Saebom, et al.
Published: (2010-03-01) -
Valproate Toxicity
by: J Gordon Millichap
Published: (1990-04-01)